New shot aims to reboot immune system in HIV patients
NCT ID NCT07443228
First seen Mar 17, 2026 · Last updated May 22, 2026 · Updated 13 times
Summary
This early-stage study tests an injection called JL18008 in HIV patients whose immune systems haven't fully recovered despite standard treatment. The goal is to see if it's safe and can improve immune function. About 52 adults aged 18-65 with well-controlled HIV but low CD4 counts will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.